Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis

Sponsor
Federal University of São Paulo (Other)
Overall Status
Unknown status
CT.gov ID
NCT00291863
Collaborator
(none)
30
1

Study Details

Study Description

Brief Summary

This study will analyse the effect of simvastatin on endothelium dependent venodilation in chronic renal failure patients treated by peritoneal dialysis. The hypothesis is that patients will have a greater endothelium dependent venodilation after four months of simvastatin use.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

This study will analyse the effect of simvastatin on endothelium dependent venodilation in chronic renal failure patients treated by peritoneal dialysis. The hypothesis is that patients will have a greater endothelium dependent venodilation after four months of simvastatin use.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Simvastatin Effect on Endothelium Dependent Venodilation in Chronic Renal Failure Patients Treated by Peritoneal Dialysis
Study Start Date :
Feb 1, 2006
Study Completion Date :
Feb 1, 2006

Outcome Measures

Primary Outcome Measures

  1. endothelial venodilation []

Secondary Outcome Measures

  1. Inflammation markers (C-reactive protein, IL-6, TNF) []

  2. Lipoproteins []

  3. Oxidative stress []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • end stage renal failure

  • peritoneal dialysis

  • LDL cholesterol > 100mg/dL

  • 18 years and < 80 years

Exclusion Criteria:
  • using statin or nitrate

  • liver disease

  • diabetes mellitus

Contacts and Locations

Locations

Site City State Country Postal Code
1 São Lucas Hospital Porto Alegre Rio Grande do Sul Brazil

Sponsors and Collaborators

  • Federal University of São Paulo

Investigators

  • Principal Investigator: Maristela Bohlke, master, Federal University of São Paulo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00291863
Other Study ID Numbers:
  • 0089/04
First Posted:
Feb 15, 2006
Last Update Posted:
Feb 16, 2006
Last Verified:
Feb 1, 2006

Study Results

No Results Posted as of Feb 16, 2006